drugset / Trial / NCT02207400

To Evaluate Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant Organisms

NCT02207400 ↗

Phase 2 Completed 246 enrolled GlaxoSmithKline
RandomizedParallel-groupSingle-blindTreatment

Summary

This study will compare the Gingival Bleeding and Gingival Inflammation following twice daily use of a sodium bicarbonate experimental dentifrice compared to a 0% sodium bicarbonate toothpaste after 24 weeks of use. The study will be conducted at Salus Research, Inc. Participants will be recruited from their database and by use of an external recruitment agency

Timeline

Start
2014-08-25
Primary completion
2015-02-01
Completion
2015-04-30

Outcome

Met primary endpoint

registry analysis (superiority or other test); Sodium Bicarbonate and Sodium Fluoride Dentifrice vs Sodium Fluoride Dentifrice; p <0.0001; Adjusted Mean Difference -11.612 (95% CI -13.191 to -10.033); ANCOVA NCT02207400 ↗

registry analysis (superiority or other test); Sodium Bicarbonate and Sodium Fluoride Dentifrice vs Sodium Fluoride Dentifrice; p <0.0001; Adjusted mean difference -0.652 (95% CI -0.738 to -0.566); ANCOVA NCT02207400 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium bicarbonate Diagnostic / imaging agent 67 % —
Subject sodium fluoride Unknown 1100 ppm —
Subject sodium fluoride Unknown 1150 ppm —

Indications

No indication recorded.